JulioSaez-Rodriguez GermanyHeidelberg University

Julio Saez-Rodriguez is Professor of Medical Bioinformatics and Data Analysis at the Faculty of Medicine of Heidelberg University, director of the Institute for Computational Biomedicine, group leader of the EMBL-Heidelberg University Molecular Medicine Partnership Unit, a member of the Heidelberg ELLIS Unit, and a co-director of the DREAM challenges. He holds a PhD in Chemical Engineering. He was a postdoctoral fellow at Harvard Medical School and M.I.T, group leader at EMBL-EBI, Cambridge, and professor of Computational Biomedicine at RWTH Aachen He is interested in developing and applying computational methods to acquire from omics data a functional understanding of biological networks and their deregulation in disease, and to apply this knowledge to develop novel therapeutics. Current emphasis in his group is on use of single-cell technologies, multi-omics integration, and understanding multi-cellular communication. Application areas include cancer, autoimmune, and cardiovascular diseases. More information at www.saezlab.org
Institution

Day 1 - Sunday April 14, 2024

Time Session
9 a.m.
10:30 a.m.
SK1001
HeatherAscani Chairperson United StatesUniversity of Michigan
KatherineTuttle Chairperson United StatesUniversity of Washington School of Medicine, Division of Nephrology
MatthiasKretzler Chairperson United StatesUniversity of Michigan
  • Looking for Data on Glomerular Diseases: How to Find the Treasures You Are Looking for With a Click of a Mouse
    VijiNair Speaker United StatesUniversity of Michigan
  • Open Science in an Open Community: Resources of the Kidney Precision Medicine Project for CKD and AKI
    MatthiasKretzler Speaker United StatesUniversity of Michigan
  • The Future is Now: How to Mine Cells and Neighborhoods of the Kidney in Health and Disease
    JulioSaez-Rodriguez Speaker julio.saez@uni-heidelberg.deGermanyHeidelberg University
  • Panel Discussion
Hall C1
SK01
HeatherReich Chairperson CanadaUniversity of Toronto, University Health Network
SebastiánJaurretche Chairperson sebastianjaurretche@hotmail.comArgentinaSanatorio Parque SA
  • Deciphering the IGAN Cell Atlas
    JulioSaez-Rodriguez Speaker julio.saez@uni-heidelberg.deGermanyHeidelberg University
  • Complement-mediated Kidney Diseases in the Era of Complement Inhibitors
    MarinaVivarelli Speaker marina.vivarelli@opbg.netItalyLaboratory of Nephrology, Bambino Gesù Children's Hospital
  • CART-T
    JonathanHogan Speaker jonathan.hogan@cabalettabio.comCabaletta Bio
  • New Targets to Reduce the Burden of Rare Kidney Diseases
    LauraMariani Speaker lmariani@umich.eduUnited StatesUniversity of Michigan
  • Q and A
Hall C4
3 p.m.
4 p.m.
SK02
RafaelMaldonado Chairperson ramaldonado@gmail.comArgentina
ReikoInagi Chairperson JapanThe University of Tokyo Graduate School of Medicine
  • Understanding Glomerular Damage: From Spatial Transcriptomics to Chip Technology
    LauraPerin Speaker LPerin@chla.usc.eduUnited States
  • Spatial Metabolomics of Kidney Disease
    TonRabelink Speaker a.j.rabelink@lumc.nlNetherlandsLUMC
  • Constructing an Epigenetic Network for Diabetic Nephropathy
    Sam El-Osta Speaker sam.el-osta@baker.edu.auAustraliaBaker Heart and Diabetes Institute
  • Q and A
Hall E

Day 2 - Monday April 15, 2024

Time Session
9 a.m.
10:30 a.m.
KI
GermaineWong Chairperson AustraliaUniversity of Sydney
PierreRonco Chairperson FranceHôpital Tenon
  • KI Highlights
    PierreRonco Speaker FranceHôpital Tenon
  • KI Highlights 1
    Eugene Yu HinChan Speaker Hong Kong, ChinaThe Chinese University of Hong Kong, Hong Kong Children's Hospital
  • KI Highlights 2
    MuzamilHassan Speaker NigeriaDepartment of Medicine, Obafemi Awolowo University, Ile-Ife, Nigeria
  • KI Highlights 3
    VeronicaMiguel Speaker SpainSpanish National Centre for Cardiovascular Research
  • KI Highlights 4
    GriffithPerkins Speaker Australia
  • KIR - Update
    JaiRadhakrishnan Speaker United StatesColumbia University in the City of New York
  • KIR Highlights 1
    SumitMohan Speaker United StatesColumbia University
  • KIR Highlights 2
    AndreaViecelli Speaker AustraliaUniversity of Queensland
  • Presentation of Best Reviewer Awards
    BradRovin Speaker United StatesThe Ohio State University
  • Presentation of Basic Science Awards (Early Career Researchers Awards)
    ChristophKuppe Speaker GermanyDepartment of Nephrology, RWTH University Aachen, Germany
  • Presentation of Clinical Science Awards (Early Career Researchers Awards)
    IsabelleAyoub Speaker United StatesThe Ohio State University
  • Q and A
    BradRovin Speaker United StatesThe Ohio State University
Hall C2
LF2002
AlejandraQuevedo Smuclir Chairperson alejandra.s.quevedo@gmail.comArgentinaSAN
CarmenTzanno Branco Martins Chairperson BrazilSLANH, ISN
SaoriNishio Chairperson saorin@med.hokudai.ac.jpJapan
  • Update of Glomerulonephritis
    FernandoFervenza Speaker fervenza.fernando@mayo.eduUnited StatesMayo Clinic
  • Inflammation and Metabolic Kidney Disease
    JunWada Speaker junwada@okayama-u.ac.jpJapanOkayama University
  • A Novel Treatment Targeting Kidney Inflammation
    Maria JoseSoler Speaker SpainHospital del Vall d´Hebron
  • Controlling Kidney Inflammation Through the Nervous System
    ShinjiTanaka Speaker shitanaka@m.u-tokyo.ac.jpJapanDivision of Nephrology and Endocrinology, the University of Tokyo Hospital
  • Q and A
Hall C3
SK03
PaulaCoccia Chairperson paula.coccia@hospitalitaliano.org.arArgentinaHospital Italianod de Buenos Aires
Shyam BihariBansal Chairperson IndiaDepartment of Nephrology, Medanta-The Medicity, Gurgaon, India
  • Genomics of Rare Genetic Diseases: Experiences From India
    VinodScaria Speaker vinods@igib.inIndiaVishwanath Cancer Care Foundation & Indian Institute of Technology Kanpur
  • On the Way to Translate GWAS into Kidney Disease Mechanisms
    KrzysztofKiryluk Speaker United StatesColumbia University
  • X-linked Kidney Disorders in Women
    MichelleRheault Speaker rheau002@umn.eduUnited StatesUniversity of Minnesota
  • Prenatal/Preimplantation Genetic Diagnosis and Genetic Counseling for Genetic Kidney Disorders
    NineKnoers Speaker v.v.a.m.knoers@umcg.nlNetherlandsDepartment of Genetics, University Medical Centre Groningen, Groningen, The Netherlands
  • Q and A
Hall E
3 p.m.
4 p.m.
LBCT
AlessiaFornoni Chairperson United StatesUniversity of Miami
MichelleRheault Chairperson rheau002@umn.eduUnited StatesUniversity of Minnesota
  • Predicting the Risks of Kidney Failure and Death in Adults With Moderate-to-severe Chronic Kidney Disease (KDpredict)
    PietroRavani Free Communication pravani@ucalgary.caCanadaUniversity of Calgary
  • Plasma Exchange in ANCA Associated Vasculitis GN: Update After Pexivas
    Wladimir MietekSzpirt Speaker wladimir.mietek.szpirt.01@regionh.dkDenmarkRigshospitalet, University of Copenhagen, Dept. of Nephrology, Denmark, Senior Research Consultant
  • EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH IgA NEPHROPATHY: INTERIM RESULTS FROM THE PHASE 3 APPLAUSE-IgAN STUDY
    DanaRizk Free Communication drizk@uabmc.eduUnited StatesUniversity of Alabama at Birmingham
  • SPARSENTAN VS IRBESARTAN IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY (IgAN): SUBGROUP ANALYSES OF 2-YEAR RESULTS FROM THE PIVOTAL PHASE 3 PROTECT TRIAL
    JonathanBarratt Free Communication United KingdomUniversity of Leicester, Leicester, UK
  • PREGNANCY AMONG WOMEN ON CHRONIC DIALYSIS : THE FRENCH COHORT
    CécileCouchoud Free Communication cecile.couchoud@biomedecine.frFranceREIN registry, Agence de la biomédecine, France
Hall A
4:30 p.m.
5:30 p.m.
SK05
DebbieGipson Chairperson debbie.gipson@nih.govUnited StatesNational Institutes of Health/NIDDK
JonathanBarratt Chairperson United KingdomUniversity of Leicester, Leicester, UK
  • Patients Subphenotyping: The Example of Diabetic Kidney Disease
    John CijiangHe Speaker cijiang.he@mssm.eduUnited StatesIcahn School of Medicine at Mount Sinai
  • Power of AI to Develop Data-driven Early Detection, Diagnosis, and Management of Kidney Disease
    LauraMariani Speaker lmariani@umich.eduUnited StatesUniversity of Michigan
  • Targeted Approaches in Clinical Trial Design
    HiddoLambers Heerspink Speaker H.J.Lambers.Heerspink@umcg.nlNetherlands
  • Q and A
Hall D

Day 3 - Tuesday April 16, 2024

Time Session
11 a.m.
12:15 p.m.
PL4
AlessiaFornoni Chairperson United StatesUniversity of Miami
LizLightstone Chairperson United KingdomImperial College London
MasaomiNangaku Chairperson Japan
  • Acceptance Speech: Bywaters Award
    MotokoYanagita Speaker JapanKyoto University
  • Insights into SGLT2 Inhibitors: A Story of Discovery. Donald Seldin Lecture
    EleFerrannini Speaker eleferrannini@gmail.comItalyUniversity of Pisa
  • ELP2 Graduation
    MasaomiNangaku Speaker Japan
Hall A
12:30 p.m.
1:30 p.m.
SK1003
AnujaJava Chairperson United StatesWASHINGTON UNIVERSITY SCHOOL OF MEDICINE IN ST. LOUIS
LizLightstone Chairperson United KingdomImperial College London
  • Complement in Kidney Disease: Overview of the Complement Cascade in Kidney Injury
    Peter Zipfel Speaker Peter.Zipfel@hki-jena.deGermanyLeibniz Institute for Natural Product Research and Infection Biology
  • C3 Glomerulopathy: New Developments and Therapeutic Targets
    CarlaNester Speaker carla-nester@uiowa.eduUnited StatesUniversity of Iowa
  • Challenges in Diagnosing C3G
    SallyJohnson Speaker sallyajohnson73@gmail.comUnited KingdomNational Renal Complement Therapeutics Centre, Newcastle Upon Tyne Hospitals NHS Foundation Trust, United Kingdom
  • Q and A
Hall C1
IK1003
Angela Yee-MoonWang Chairperson SingaporeHong Kong/Singapore
ArmandoNegri Chairperson armando.negri@gmail.comArgentinaInstituto de Investigaciones Metabólicas, Universidad del Salvador, Buenos Aires, Argentina
  • CKD-induced Changes in Gut Microbiome in CKD
    DeniseMafra Speaker dmafra30@gmail.comBrazilFederal University Fluminense - UFF
  • Personalized Nutrition Management of CKD Patients
    ConnieRhee Speaker crhee@mednet.ucla.eduUnited StatesUCLA
  • The Gut-Kidney-Heart Axis in CKD: Beyond the Leaky Gut
    KeiichiSumida Speaker ksumida@uthsc.eduUnited StatesUniversity of Tennessee Health Science Center
  • Q and A
Hall C4